Cost-effectiveness of the hepatitis B birth-dose vaccine in South Africa: a mathematical modelling analysis.

Seaman C, Bailie C, Spearman CW, Sonderup M, Howell J, Hellard M, Scott N

Open source

DOI
10.1016/j.langlo.2026.103975
Published
2027 Aug 24
Container
The Lancet. Global health
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.langlo.2026.103975,
  title = {Cost-effectiveness of the hepatitis B birth-dose vaccine in South Africa: a mathematical modelling analysis.},
  author = {Seaman C and Bailie C and Spearman CW and Sonderup M and Howell J and Hellard M and Scott N},
  year = {2027},
  journal = {The Lancet. Global health},
  doi = {10.1016/j.langlo.2026.103975},
  url = {https://doi.org/10.1016/j.langlo.2026.103975}
}

RIS

TY  - JOUR
TI  - Cost-effectiveness of the hepatitis B birth-dose vaccine in South Africa: a mathematical modelling analysis.
AU  - Seaman C
AU  - Bailie C
AU  - Spearman CW
AU  - Sonderup M
AU  - Howell J
AU  - Hellard M
AU  - Scott N
PY  - 2027
JO  - The Lancet. Global health
DO  - 10.1016/j.langlo.2026.103975
UR  - https://doi.org/10.1016/j.langlo.2026.103975
ER  - 

APA

C, S., C, B., CW, S., M, S., J, H., M, H., & N, S. (2027). Cost-effectiveness of the hepatitis B birth-dose vaccine in South Africa: a mathematical modelling analysis.. The Lancet. Global health. https://doi.org/10.1016/j.langlo.2026.103975

Source records